CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: February 3, 2005
Result type: Reports
Project Number: S0032
Product Line: Common Drug Review

Generic Name: Laronidase

Brand Name: Aldurazyme

Manufacturer: Genzyme Canada

Indications: Mucopolysaccharidosis 1 (MPS 1), Hurler, Hurler-Scheie, Scheie

Submission Type: New

Project Status: Complete

Date Recommendation Issued: July 14, 2005

Recommendation Type: Do not list